Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

DETermination of the Role of OXygen in Suspected Acute Myocardial Infarction (DETO2X-AMI) Based on the SWEDEHEART Registry

NCT01787110 is registered in ClinicalTrials.gov with Karolinska Institutet as lead sponsor.

NCT NCT01787110
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01787110 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
DETermination of the Role of OXygen in Suspected Acute Myocardial Infarction (DETO2X-AMI) Based on the SWEDEHEART Registry
Lead sponsor
Karolinska Institutet
Phase
Phase 3
Overall status
Completed
Start date
April 30, 2013
Completion date
December 30, 2016
Enrollment
6,629 (actual)
Sites
34

Conditions

As the registry lists them; a condition with its own page is linked.

acute coronary syndrome, acute st segment elevation myocardial infarction, angina, unstable, non-st elevation (nstemi) myocardial infarction